---
title: "300298.SZ (300298.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300298.SZ/news.md"
symbol: "300298.SZ"
name: "300298.SZ"
parent: "https://longbridge.com/en/quote/300298.SZ.md"
datetime: "2026-05-21T03:39:31.369Z"
locales:
  - [en](https://longbridge.com/en/quote/300298.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300298.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300298.SZ/news.md)
---

# 300298.SZ (300298.SZ) — Related News

### [CDMO leader Samsung Biologics strikes: Is there an order transfer window for Chinese CDMO companies?](https://longbridge.com/en/news/285721192.md)
*2026-05-08T09:29:15.000Z*
> The global biopharmaceutical CDMO industry leader Samsung Biologics is facing a significant operational crisis due to a 

### [Sinocare: First repurchase of 2.223 million shares at a cost of 37.4498 million yuan](https://longbridge.com/en/news/285692007.md)
*2026-05-08T08:49:17.000Z*
> Sinocare announced that the company repurchased 2.223 million shares for the first time through centralized bidding on M

### [Sinocare: Subsidiary product TRUE METRIX® series blood glucose monitoring system recall action](https://longbridge.com/en/news/285285202.md)
*2026-05-06T00:17:02.000Z*
> Sinocare announced that its holding subsidiary Trividia Health Inc. has initiated an emergency medical device correction

### [Sinocare: The EU's temporary ban ruling has not caused a disruption in the production of the company's CGM products](https://longbridge.com/en/news/285211552.md)
*2026-05-05T12:49:24.000Z*
> Sinocare (300298) stated on May 5th that the temporary injunction from the EU court did not cause any interruption in th

### [Increasing investment in CGM+ globalization + AI, where does Sinocare's confidence come from?](https://longbridge.com/en/news/284765414.md)
*2026-04-30T11:56:12.000Z*
> Sinocare disclosed in its 2025 annual report that revenue was 4.659 billion yuan, a year-on-year increase of 4.87%, but 

### [Sinocare Showcases Digital Innovation at the 93rd CMEF, Advancing Global Chronic Disease Management](https://longbridge.com/en/news/282423046.md)
*2026-04-11T16:45:42.000Z*
> In Shanghai on April 11, 2026, Sinocare unveiled its latest innovations at the 93rd China International Medical Equipmen

### [Sinocare: Discloses the shareholding status of the top ten shareholders and shareholders with no selling restrictions before the share repurchase announcement](https://longbridge.com/en/news/282011729.md)
*2026-04-08T09:28:32.000Z*
> Sinocare announced that the company will hold a board meeting on March 27, 2026, to decide on the repurchase of shares f

### [](https://longbridge.com/en/news/282012390.md)
*2026-04-08T09:24:49.000Z*
> Sinocare: Obtained a commitment letter for a special loan for stock repurchase from a financial institution, with a borr

### [Daily Investment and Financing Report in the Healthcare Sector (April 2): Shize Biotechnology Completes RMB 500 Million Series C+ Financing](https://longbridge.com/en/news/281582930.md)
*2026-04-02T23:01:09.000Z*
> On April 2, 2026, a total of 6 financing events were disclosed in the healthcare sector, with a total financing amount o